Tirofiban Hydrochloride Patent Expiration

Tirofiban Hydrochloride is Used for reducing thrombotic coronary events in patients with acute coronary syndrome. It was first introduced by Medicure International Inc in its drug Aggrastat on May 14, 1998. 4 different companies have introduced drugs containing Tirofiban Hydrochloride.


Tirofiban Hydrochloride Patents

Given below is the list of patents protecting Tirofiban Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Aggrastat US5733919 Compositions for inhibiting platelet aggregation Oct 23, 2016

(Expired)

Medicure
Aggrastat US5733919 Compositions for inhibiting platelet aggregation Oct 23, 2016

(Expired)

Medicure
Aggrastat US5965581 Compositions for inhibiting platelet aggregation Oct 23, 2016

(Expired)

Medicure
Aggrastat US5972967 Compositions for inhibiting platelet aggregation Oct 23, 2016

(Expired)

Medicure
Aggrastat US5978698 Angioplasty procedure using nonionic contrast media Oct 08, 2017

(Expired)

Medicure
Aggrastat US6136794 Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist Jan 29, 2019

(Expired)

Medicure
Aggrastat US6770660 Method for inhibiting platelet aggregation May 01, 2023

(Expired)

Medicure


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Tirofiban Hydrochloride Generics

Several generic applications have been filed for Tirofiban Hydrochloride. The first generic version for Tirofiban Hydrochloride was by Gland Pharma Ltd and was approved on Apr 8, 2021. And the latest generic version is by Nexus Pharmaceuticals Llc and was approved on Jul 24, 2023.

Given below is the list of companies who have filed for Tirofiban Hydrochloride generic.


1. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 1 generic for Tirofiban Hydrochloride. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) solution Prescription INTRAVENOUS AP Apr 8, 2021


2. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Tirofiban Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) solution Prescription INTRAVENOUS AP May 1, 2023
EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) solution Prescription INTRAVENOUS AP May 1, 2023


3. NEXUS

Nexus Pharmaceuticals Llc has filed for 2 different strengths of generic version for Tirofiban Hydrochloride. Given below are the details of the strengths of this generic introduced by Nexus.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) solution Prescription INTRAVENOUS AP Feb 7, 2023
EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) solution Prescription INTRAVENOUS AP Jul 24, 2023